Endothelial cell activation by tumor necrosis factor elicits human antiporcine cell-mediated rejection responses

Transplant Proc. 2001 Feb-Mar;33(1-2):412-3. doi: 10.1016/s0041-1345(00)02072-8.

Authors

N C Kirkiles-Smith¹, D A Tereb, R W Kim, J M McNiff, J S Schechner, M I Lorber, J S Pober, G Tellides

Affiliation

¹ Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 11266888
DOI: 10.1016/s0041-1345(00)02072-8

No abstract available

MeSH terms

Adult
Animals
Cytokines / metabolism
Endothelium, Vascular / drug effects*
Endothelium, Vascular / immunology
Graft Rejection / immunology*
Histocompatibility Antigens Class I / drug effects
Histocompatibility Antigens Class I / metabolism
Histocompatibility Antigens Class II / drug effects
Histocompatibility Antigens Class II / metabolism
Humans
Lymphocyte Activation / drug effects*
Lymphocyte Activation / immunology
Mice
Mice, SCID
Models, Animal
Skin Transplantation / immunology
Species Specificity
Swine
T-Lymphocytes / drug effects*
T-Lymphocytes / immunology
Transplantation Chimera / immunology
Transplantation Tolerance / immunology*
Transplantation, Heterologous
Tumor Necrosis Factor-alpha / administration & dosage
Tumor Necrosis Factor-alpha / pharmacology*

Substances

Cytokines
Histocompatibility Antigens Class I
Histocompatibility Antigens Class II
Tumor Necrosis Factor-alpha